Evaluation of PK and Safety of D-0120 and Allopurinol

• Status: Active, not recruiting
• Trial end date: 2022-04-23
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of safety and PK interaction between D-0120 and Alopurinol in healthy adult subjects

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: InventisBio Co., Ltd
• Treatments: Allopurinol

Criteria

Inclusion Criteria:

• Healthy subjects between the ages of 18-55

• Required evaluation by Investigator for screening and enrollment

• Agreement and compliance with the study and follow-up procedures

Exclusion Criteria:

• Significant medical history or current comorbidly determined by the Investigator.

• Pregnant or nursing women